Biologics in severe asthma: a state-of-the-art review
Asthma is considered severe if it remains uncontrolled despite optimal conventional therapy, characterised by poor symptom control, frequent exacerbations and increased exposure to systemic corticosteroids. This has a significant impact on morbidity, mortality and healthcare resource utilisation. Re...
| Published in: | European Respiratory Review |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2024-01-01
|
| Online Access: | http://err.ersjournals.com/content/34/175/240088.full |